CurrentCentenePolicy CP.MP.184

Home Ventilators

Customize your policy alerts

Sign up for Centene Policy CP.MP.184 alerts

Get alerted when Policy CP.MP.184 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Medical necessity criteria for coverage of noninvasive and invasive home ventilators for non‑Medicare health plans affiliated with Centene, including initial and continued use, backup devices, and indications such as restrictive thoracic disorders, COPD, and obesity hypoventilation syndrome.

Policy Summary

PayerCentene

PolicyHome Ventilators

Policy CodePolicy CP.MP.184

Change TypeNo material clinical or coverage changes

Effective Date

Next Review Date

Key ActionSubmit prior authorization with clinical documentation demonstrating required diagnostic thresholds and that RAD/CPAP are not appropriate.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentCentenePolicy CP.MP.184

Home Ventilators

Customize your policy alerts

Sign up for Centene Policy CP.MP.184 alerts

Get alerted when Policy CP.MP.184 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerCentene

PolicyHome Ventilators

Policy CodePolicy CP.MP.184

Change TypeNo material clinical or coverage changes

Effective Date

Next Review Date

Key ActionSubmit prior authorization with clinical documentation demonstrating required diagnostic thresholds and that RAD/CPAP are not appropriate.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

major criteria sections

4HCPCS codes referenced

1non‑Medicare policy

4+clinical references cited

Medical Necessity Criteria

Initial therapy — Restrictive thoracic disorders (first three months)

Covered when ALL of the following are met:

I.A: Documentation of a neuromuscular disease or severe thoracic cage abnormality AND one of specified respiratory measurements taken while stable (not in acute respiratory failure)see children/adult specifics

Measurements include PaCO2 ≥ 45 mm Hg; sleep oximetry O2 saturation ≤ 88% for ≥5 minutes; if neuromuscular disease, maximal inspiratory pressure < 60 cm H2O or FVC < 50% predicted.

I.A.2: Documentation supports both that member could not be appropriately treated with a respiratory assist device (RAD) AND the non-invasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

I.A.3: Chronic obstructive pulmonary disease (COPD) does not contribute significantly to the pulmonary limitation

Initial therapy — Chronic respiratory failure due to COPD (first three months)

Covered when ALL of the following are met:

I.B.1: Member exhibits hypercapnia: PaCO2 ≥ 52 mm Hg by arterial blood gas obtained while awake and breathing prescribed FiO2

I.B.2: Sleep apnea is not the predominant cause of the hypercapnia

I.B.3

Requires oxygen therapy at FiO2 ≥ 36% or ≥4 L nasally
Requires ventilatory support for >8 hours per 24-hour period
Requires a home mechanical ventilator with alarms and internal battery because member cannot effectively breathe independently for more than a few hours and interruption would be life‑threatening

Initial therapy — Obesity hypoventilation syndrome (OHS)

Covered when ALL of the following are met:

I.C.1: BMI ≥ 30

I.C.2: Initial arterial blood gas PaCO2 at baseline while awake and on prescribed FiO2 ≥ 45 mm Hg

I.C.3: Sleep‑disordered hypoventilation documented by polysomnography and other causes of hypoventilation are not the primary cause

I.C.4: Documentation supports both that RAD is not appropriate AND the non‑invasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

Continuation therapy — Noninvasive ventilators

Covered when ALL of the following are met:

II.A: Device is used for at least an average of 4 hours per 24‑hour period

II.B: Documentation supports both ongoing benefits from use AND that the noninvasive home ventilator is not being used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

Overlap syndromes

III: Overlap syndromes (e.g., COPD and sleep apnea) require secondary review by a medical director

Invasive ventilator — Initial and ongoing use

IV: Initial and ongoing use of an invasive ventilator is medically necessary for long‑term or chronic conditions that impair the ability to maintain adequate respiratory status (examples include neuromuscular disease, thoracic restrictive disease, or chronic respiratory failure following COPD)

Second or backup ventilator

Covered when ANY of the following are met:

V.A: Second ventilator is needed to serve a different purpose from the first based on medical needs (e.g., different types required across day/night)

V.B.1: Back‑up ventilator when member is wheelchair‑confined and requires a wheelchair‑mounted ventilator during the day plus another for use in bed because the wheelchair cannot be positioned for sleep

V.B.2: Back‑up ventilator when residence is in a remote area with poor emergency access

General policy foundation

This portion does not contain specific medical necessity criteria.

policy basis: Policy was developed from accepted standards, peer-reviewed literature, government approvals, evidence-based guidelines, expert opinion and other clinical information.

Informational only from chunks 18-19

The policy specifies that a noninvasive home ventilator must not be used to provide respiratory assist device (RAD) or CPAP therapy. Documentation supporting ventilator use must confirm that the device will be used to provide ventilatory support (e.g., average volume‑assured pressure support) and that RAD/CPAP alone would be insufficient; use of RAD or CPAP alone does not meet the policy’s criteria for a home ventilator.

This clinical policy provides guidance on medical necessity and is intended to assist coverage decision‑making; it does not constitute medical advice or a guarantee of payment. Coverage and benefits remain subject to the terms, conditions, exclusions, and limitations of the member’s coverage documents and applicable legal and regulatory requirements.

Prior policy language that required documentation of BiPAP failure or listed BiPAP contraindications has been removed. The current policy requires documentation that the member "could not be appropriately treated with a RAD" and that the noninvasive home ventilator "will not be used to provide RAD or CPAP therapy." The record should therefore explicitly state that RAD is not appropriate rather than relying on prior BiPAP‑failure criteria.

No explicit items labelled as "not medically necessary" are specified in the cited portions of this document. The policy focuses on defining medical necessity criteria and reminders about provider responsibility and plan terms rather than enumerating standalone noncovered services in these chunks.

Billing and Codes

Covered HCPCS Codes for home ventilatorsHCPCSCovered

E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube).
E0466	Home ventilator, any type, used with noninvasive interface, (e.g., mask, chest shell).
E0467	Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions.
E0468	Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions.

Covered CPT Codesmixed

N/A	No specific CPT/HCPCS/ICD-10 codes listed in these chunks

PaCO2 thresholds — applicable indications

Restrictive thoracic disordersPaCO2 ≥ 45 mm Hg (measured while awake and breathing room air or prescribed FiO2)

COPD-related chronic respiratory failurePaCO2 ≥ 52 mm Hg (arterial blood gas obtained while awake and breathing prescribed FiO2)

Obesity hypoventilation syndrome (OHS)PaCO2 ≥ 45 mm Hg (initial arterial blood gas done while awake and breathing baseline prescribed FiO2)

Oxygen requirement threshold

Oxygen therapy requirementRequires oxygen therapy at FiO2 ≥ 36%

Equivalent nasal flowOr requires ≥ 4 L per minute delivered nasally

What Providers Must Do

Prior Authorization

Prior authorization required with clinical documentation

Prior authorization is required for home ventilators. Submit clinical documentation that demonstrates the member meets the policy's medical necessity criteria for the specific indication (restrictive thoracic disorder, COPD-related chronic respiratory failure, or obesity hypoventilation syndrome) and shows that a respiratory assist device (RAD) or CPAP is not appropriate and the ventilator will not be used to provide RAD/CPAP therapy.

Include indication-specific measurements (e.g., PaCO2 thresholds, sleep oximetry, BMI, MIP or FVC when applicable).
Document that RAD/CPAP is not appropriate and the ventilator will be used to provide average volume assured pressure support, not RAD/CPAP.

Note

Review NCDs/LCDs and Medicare coverage articles first

Before applying the clinical criteria in this policy, review applicable Medicare NCDs, LCDs, and Medicare Coverage Articles as needed to ensure consistency with Medicare determinations.

Consult the CMS website for current NCDs, LCDs, and Coverage Articles when treating Medicare members or when Medicare criteria may inform clinical assessment.

Clinical Background

Respiratory failure is the inability to maintain adequate oxygenation or ventilation and may be acute or chronic. Noninvasive ventilation (NIV) refers to delivery of positive airway pressure via noninvasive interfaces (for example, masks or nasal pillows) to support ventilation in patients with chronic or progressive respiratory insufficiency. NIV in the home setting is used to improve ventilation, reduce symptoms and hospital readmissions, and support patients with conditions such as neuromuscular disease, severe thoracic cage abnormalities, chronic obstructive pulmonary disease (COPD) with chronic hypercapnia, and obesity hypoventilation syndrome when the policy’s medical necessity criteria are met.

Key Definitions

Noninvasive ventilation (NIV) — definition and interfaces

DefinitionNoninvasive ventilation (NIV) is administration of positive pressure to the lungs using interfaces such as nasal masks, orofacial masks, full face masks, mouthpieces, nasal pillows, or helmets.

Typical interfacesExamples include nasal mask, oronasal (full‑face) mask, nasal prongs, nasal pillows, mouthpiece, and helmet interfaces.

Primary goalUsed to support ventilation and improve oxygenation/CO2 elimination in acute and chronic respiratory failure without an invasive airway.

Invasive ventilatory support — definition and typical interfaces

DefinitionInvasive ventilatory support is administration of positive pressure to the lungs via an invasive interface such as a tracheostomy tube or endotracheal tube.

Typical interfaces

Policy Summary

PayerCentene

PolicyHome Ventilators

Policy CodePolicy CP.MP.184

Change TypeNo material clinical or coverage changes

Effective Date

Next Review Date

Key ActionSubmit prior authorization with clinical documentation demonstrating required diagnostic thresholds and that RAD/CPAP are not appropriate.

SourceLink

On This Page

I.B.4: Documentation supports both that RAD is not appropriate AND ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

Use-time threshold for continuation

Minimum average daily useAverage of at least 4 hours per 24-hour period

Continuation documentationOngoing benefit must be documented in the record along with average use ≥4 hours/24 hours

BMI threshold for obesity hypoventilation syndrome (OHS)

BMI cutoff for OHSBMI ≥ 30

Associated requirementsBMI ≥30 plus baseline awake PaCO2 ≥45 mm Hg and polysomnography documenting sleep‑disordered hypoventilation

N/A

N/ANo specific threshold or value applicable

Policy noteThis placeholder indicates no additional numeric threshold in this category

Step Therapy

Step therapy: document RAD trial or inappropriateness

Document that the member could not be appropriately treated with a respiratory assist device (RAD) prior to approval of a home ventilator; the policy requires evidence RAD/CPAP are not appropriate and the ventilator will not be used to provide RAD/CPAP therapy.

For initial requests in I.A, I.B, and I.C include explicit documentation that RAD was tried or determined inappropriate.
State that the ventilator will provide average volume assured pressure support rather than RAD/CPAP.

Documentation Required

Required clinical documentation and measurements

Include complete clinical documentation to support medical necessity and prior authorization decisions, including primary diagnosis, relevant measurements (PaCO2 or sleep oximetry), and evidence regarding RAD/CPAP appropriateness.

Diagnosis (e.g., neuromuscular disease, severe thoracic cage abnormality, COPD, or OHS).
Arterial blood gas PaCO2 values per indication (e.g., ≥45 mm Hg for restrictive disorders or OHS; ≥52 mm Hg for COPD) or sleep oximetry results (O2 saturation ≤88% ≥5 minutes).
When neuromuscular disease is present, include maximal inspiratory pressure (<60 cm H2O) or FVC (<50% predicted) if applicable.
For continuation requests include average use ≥4 hours per 24-hour period and documentation of ongoing benefit.

Documentation Required

Provider responsibility and medical judgment

Providers must exercise professional medical judgment and remain responsible for the medical advice and treatment of members; this policy is a medical necessity guide and does not replace provider documentation responsibilities in the medical record.

The policy does not constitute medical advice or dictate clinical practice; providers are independent and solely responsible for care.
Maintain thorough medical record documentation to support any authorization or claims submission.

Denial Risk

Denial risk if diagnostic criteria or RAD documentation missing

Requests may be denied if submitted documentation does not demonstrate required diagnostic criteria (for example, PaCO2 thresholds, BMI for OHS, or documentation that RAD/CPAP are not appropriate) or if COPD significantly contributes to the pulmonary limitation when restrictive disorder criteria are cited.

Failure to document PaCO2 at required thresholds (e.g., ≥45 mm Hg for restrictive disorders/OHS; ≥52 mm Hg for COPD) can trigger denial.
Lack of evidence that RAD/CPAP are inappropriate or that COPD does not significantly contribute when citing restrictive disorder criteria may lead to denial.

Note

Coverage subject to member plan terms and exclusions

Coverage and benefit administration are subject to all terms, conditions, exclusions and limitations of the member's coverage documents; lack of conformity with those documents may result in denial or limited payment.

Verify the member's evidence of coverage, certificate, or contract for any plan-specific exclusions or limitations before ordering equipment.

Common invasive interfaces include tracheostomy tubes and endotracheal tubes for patients requiring airway protection or full ventilatory support.

Clinical useOften used when patients cannot maintain spontaneous breathing or when noninvasive ventilation is contraindicated (e.g., airway protection).

Clinical policy purpose — medical necessity guide

PurposeThis clinical policy provides a guide to medical necessity to assist in coverage decisions and administering benefits.

Not a guaranteeThe policy does not constitute a contract, guarantee of payment, or medical advice; coverage remains subject to plan terms and applicable laws.

Development basisPolicy was developed from accepted standards, peer‑reviewed literature, government approvals, evidence‑based guidelines, and expert clinical opinion.